Discover How Psychedelics Are Revolutionizing Mental Health Treatment with Niko Skievaski, co-founder and CEO of Althea

Outcomes Rocket

Psychedelics can help individuals navigate significant life challenges and gain new perspectives.

In this episode, Niko Skievaski, co-founder and CEO of Althea, discusses the transformative potential of psychedelics in mental health. Niko explains the growing evidence that psychedelics can offer better outcomes than traditional psychiatric treatments for conditions like PTSD, depression, and addiction. Throughout this interview with Saul Marquez, he talks about the resurgence of research at top institutions, the development of new software to support regulatory compliance and practice management, and the bipartisan support for psychedelic programs. Niko also shares personal stories on psychedelics and societal issues like AI, climate change, and political unrest, while highlighting an entrepreneur's journey in health tech and the need for a more inclusive and effective approach to mental health.

Tune in and learn about the future of psychedelics in healthcare and the innovative efforts to integrate these treatments into mainstream medicine!

Resources:

• Watch the entire interview here.
• Connect and follow Niko Skievaski on LinkedIn.
• Learn more about Althea on their LinkedIn and website.
• Listen to Niko’s previous interview on our podcast here.